ClariPulmo

AI 3D lung reporting solution for low-dose lung CT screenings.

Book a meeting
Pulmo-02-qbx5fn95ngd9fiowxhpgkbh0rzbpw2u1md3ir4kkpy

Overview

ClariPulmo is a non-invasive image analysis software specifically developed for the precise quantification of lung CT images, aiming to assist physicians in diagnosing and documenting pulmonary tissue images, particularly abnormalities from CT thoracic datasets.

The software utilizes automated lung segmentation techniques and predefined Hounsfield unit thresholds to accurately quantify both low-attenuation and high-attenuation areas within the segmented lungs. Furthermore, ClariPulmo generates easily interpretable reports, featuring color-coded visual representations of the segmented lungs and analysis results, ensuring efficient everyday workflow.

 

ClariPulmo2-768x768

Features

  • Quantification of low attenuation area (LAA) and high attenuation area (HAA).
  • Provides lung volume, LAA/HAA volume and percentage in table and pie chart format.
  • Provides overview of lung in 3D with severity level and percentage.
  • Colored overlay of upper, middle and lower lung zones.
  • DICOM compliant for seamless integration with existing CT equipment and PACS.
  • Lung nodule detection (CE marked only).
Thoracic-icon-150x150
MRI-icon-2-150x150
FDA-_-CE-icon-150x150

Benefits

  • Designed to support physicians in diagnosis and documentation of pulmonary tissue images (e.g. abnormalities) from CT images.
  • Offers patient condition monitoring and tracking.
  • Aimed to streamline radiologists’ workflow.

    Diagnostic performance: 
     
  • The HAA analysis showed excellent agreement (PCC: 0.980 – 0.983) with expert-established segmentations of user-defined high attenuation areas. The test dataset used for manual vs threshold-based segmentations included patients with pneumonia and COVID-19.
     
  • The LAA analysis showed excellent agreement (PCC: 0.99) with expert-established segmentations of user-defined low attenuation areas. The test dataset used for manual vs threshold-based segmentations included both healthy and diseased patients.

Image examples

ClariPulmo Reports
CE Feature - ClariPulmo Nodule

To find out more about this solution or any of the other 140+ applications on the Blackford Platform, please book a discovery call with our team.

review image 1

Book a meeting

We’d welcome the opportunity to learn more about your AI needs and to explain how partnering with Blackford can drive efficiency and provide ongoing value.

Book a Meeting